TOHO HOLDINGS CO., LTD. reported net sales of 539,360 million yen for the first half of fiscal year 2012, a 3.8% increase year-over-year.
See it on page 1Profitability declined significantly during the period, with operating income falling 18.8% to 4,110 million yen and net income dropping 8.9% to 3,364 million yen.
See it on page 9The dispensing pharmacy operations segment emerged as a growth engine, recording a 14.5% increase in net sales.
See it on page 4Operating cash flow resulted in a 5,926 million yen outflow, primarily driven by working capital changes and a decrease in notes and accounts payable.
See it on page 5The company maintained its full-year earnings forecast despite concerns regarding upcoming national health insurance drug price revisions.
See it on page 5Strategic expansion efforts during the period included the acquisition of SHOUEI CO., LTD. and the development of new distribution infrastructure in Kyushu.
See it on page 4TOHO HOLDINGS CO., LTD. released its consolidated financial results for the first half of the fiscal year ending March 2012, covering the period from April 1, 2011, to September 30, 2011. The report outlines the company’s operational performance, financial position, and cash flow status within the Japanese pharmaceutical wholesaling and related healthcare service sectors. The primary objective of the document is to provide stakeholders with a transparent account of the group’s financial health and strategic progress, including business expansion through the acquisition of SHOUEI CO., LTD. and the establishment of new distribution infrastructure in Kyushu.
During this period, the company achieved net sales of 539,360 million yen, representing a 3.8% increase compared to the same period in the previous fiscal year. Despite this growth in top-line revenue, profitability metrics declined: operating income fell by 18.8% to 4,110 million yen, ordinary income decreased by 15.1% to 6,059 million yen, and net income dropped by 8.9% to 3,364 million yen. The pharmaceutical wholesaling segment remained the primary revenue driver, while the dispensing pharmacy operations segment demonstrated significant growth, recording a 14.5% increase in net sales.
The financial position as of September 30, 2011, showed total assets of 515,965 million yen and total net assets of 114,884 million yen. Cash flow from operating activities resulted in an outflow of 5,926 million yen, largely influenced by changes in working capital, including a decrease in notes and accounts payable. The company maintained its full-year earnings forecast, citing potential uncertainties regarding upcoming national health insurance drug price revisions. The report adheres to standard Japanese accounting practices and reflects the company’s ongoing efforts to optimize distribution and enhance customer support systems.